CXCL9 and cancer: However, we found that Siglec15 may exert an immunosuppressive function by comprehensively downregulating the expression of critical immunomodulators such as CXCL9, CXCL10, and CXCR3, and subsequently downregulating the activities of the cancer-immunity cycle.